相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study*
L. Gianni et al.
ANNALS OF ONCOLOGY (2022)
Quiescent cancer cells resist T cell attack by forming an immunosuppressive niche
Pilar Baldominos et al.
CELL (2022)
Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial
Eric P. Winer et al.
LANCET ONCOLOGY (2021)
Inhibition of Jumonji Histone Demethylases Selectively Suppresses HER2+ Breast Leptomeningeal Carcinomatosis Growth via Inhibition of GMCSF Expression
Arunoday Bhan et al.
CANCER RESEARCH (2021)
Subclonal heterogeneity and evolution in breast cancer
Ioanna Mavrommati et al.
NPJ BREAST CANCER (2021)
Breast tumours maintain a reservoir of subclonal diversity during expansion
Darlan C. Minussi et al.
NATURE (2021)
Inhibition of resistant triple-negative breast cancer cells with low-dose 6-mercaptopurine and 5-azacitidine
Balraj Singh et al.
Oncotarget (2021)
Molecular Biology and Evolution of Cancer: From Discovery to Action
Jason A. Somarelli et al.
MOLECULAR BIOLOGY AND EVOLUTION (2020)
Pembrolizumab for Early Triple-Negative Breast Cancer
Peter Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Evaluation of 6-mercaptopurine in a cell culture model of adaptable triple-negative breast cancer with metastatic potential
Balraj Singh et al.
Oncotarget (2019)
Inflammatory Breast Cancer What to Know About This Unique, Aggressive Breast Cancer
Arjun Menta et al.
SURGICAL CLINICS OF NORTH AMERICA (2018)
A usable model of "decathlon winner" cancer cells in triple-negative breast cancer: survival of resistant cancer cells in quiescence
Balraj Singh et al.
Oncotarget (2018)
JIB-04, A Small Molecule Histone Demethylase Inhibitor, Selectively Targets Colorectal Cancer Stem Cells by Inhibiting the Wnt/β-Catenin Signaling Pathway
Min Seong Kim et al.
SCIENTIFIC REPORTS (2018)
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth
Janet K. Parrish et al.
Oncotarget (2018)
Increasing G9a automethylation sensitizes B acute lymphoblastic leukemia cells to glucocorticoid-induced death
Coralie Poulard et al.
CELL DEATH & DISEASE (2018)
Small molecules targeting histone demethylase genes (KDMs) inhibit growth of temozolomide-resistant glioblastoma cells
Barbara Banelli et al.
ONCOTARGET (2017)
Taxane-Platin-Resistant Lung Cancers Co-develop Hypersensitivity to JumonjiC Demethylase Inhibitors
Maithili P. Dalvi et al.
CELL REPORTS (2017)
Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer
Wolfgang J. Janni et al.
CLINICAL CANCER RESEARCH (2016)
Important Role of FTO in the Survival of Rare Panresistant Triple-Negative Inflammatory Breast Cancer Cells Facing a Severe Metabolic Challenge
Balraj Singh et al.
PLOS ONE (2016)
Highly Adaptable Triple-Negative Breast Cancer Cells as a Functional Model for Testing Anticancer Agents
Balraj Singh et al.
PLOS ONE (2014)
Inflammatory breast cancer (IBC): clues for targeted therapies
Sandra V. Fernandez et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Influence of Metabolism on Epigenetics and Disease
William G. Kaelin et al.
CELL (2013)
Mechanisms Governing Metastatic Dormancy and Reactivation
Filippo G. Giancotti
CELL (2013)
A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth
Lei Wang et al.
NATURE COMMUNICATIONS (2013)
Selection of Metastatic Breast Cancer Cells Based on Adaptability of Their Metabolic State
Balraj Singh et al.
PLOS ONE (2012)
Triple-Negative Subtype Predicts Poor Overall Survival and High Locoregional Relapse in Inflammatory Breast Cancer
Jing Li et al.
ONCOLOGIST (2011)
Evaluation of a CXCR4 antagonist in a xenograft mouse model of inflammatory breast cancer
Balraj Singh et al.
CLINICAL & EXPERIMENTAL METASTASIS (2010)
COX-2 involvement in breast cancer metastasis to bone
B. Singh et al.
ONCOGENE (2007)
A pooled analysis of bone marrow micrometastasis in breast cancer
S Braun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
分享论文
